BioVie holders approve 7.8x increase in 2019 equity plan share reserve at annual meeting

BIOVIE INC.

Stockholders approved amending the 2019 Omnibus Equity Incentive Plan to raise shares available for issuance from 399,509 to 3,100,000, roughly a 7.8x increase.
The plan amendment drew the heaviest opposition: 1,020,704 for, 689,489 against, 136,939 abstained, with 2,902,235 broker non-votes.
All six director nominees elected, including Amy Chappell (1,732,353 for / 114,779 withheld), Cuong Do, Kameel Farag, James Lang, Sigmund Rogich and Michael Sherman.
EisnerAmper LLP ratified as independent auditor for fiscal year ending June 30, 2027 (4,411,653 for, 274,205 against, 63,509 abstain).
Quorum met with 4,749,367 of 8,682,710 Class A shares outstanding on the Sept 21, 2026 record date present by proxy or virtually.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.